83 participants
Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-13
- Start Date:
- 2022-03-29
- Completion:
- 2025-07-01
Conditions
- EBV
- Epstein-Barr Virus Infection
- Infectious Mononucleosis
Interventions
- BIOLOGICAL